Cargando…
Exploring the methylation status of CFTR and PKIA genes as potential biomarkers for lung adenocarcinoma
BACKGROUND: One of the most prevalent cancers in the world is lung cancer, with adenocarcinoma (LUAD) making up a significant portion of cases. According to the National Cancer Institute (NCI), there are new cases and fatality rates per 100,000 individuals as follows: New instances of lung and bronc...
Autores principales: | Xu, Bowen, Zhang, Jingang, Chen, Weigang, Cai, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466921/ https://www.ncbi.nlm.nih.gov/pubmed/37644544 http://dx.doi.org/10.1186/s13023-023-02807-1 |
Ejemplares similares
-
Silencing of lncRNA PKIA-AS1 Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain Through Epigenetic Downregulation of CDK6 Expression
por: Hu, Jian-Zhong, et al.
Publicado: (2019) -
Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018) -
Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma
por: Han, Liankui, et al.
Publicado: (2018) -
Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma
por: Li, Gaopeng, et al.
Publicado: (2022) -
Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS
metabolomics
por: Mo, Liang, et al.
Publicado: (2020)